Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ExpoBiome

Financiado

Cerrado

Deciphering the impact of exposures from the gut microbiome derived molecular co...

Deciphering the impact of exposures from the gut microbiome derived molecular complex in human health and disease The human gut microbiome is a complex ecosystem, which contributes essential functions to human physiology. Changes to the microbiome are associated with several chronic diseases characterised by inflammation, including neurodegen... ver más

31/10/2025

uni.lu

2M€

Presupuesto del proyecto: 2M€

Líder del proyecto

UNIVERSITE DU LUXEMBOURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-02-17

ERC-2019-COG: ERC Consolidator Grant

I+D

Cerrada hace 5 años

0% 100% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

2 Participantes

uni.lu

2.00M€ | Lider

GOMPLAST

398.00K€ | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

IMMEDIATE Imminent Disease Prediction and Prevention at the Environmen... 6M€ Cerrado

MITI 2 Gut Microbiota-Induced Tregs for Inflammatory-Bowel-Disease... 6M€ Cerrado

MiRNA-AIEC Role of microRNAs in host responses to Crohn s disease assoc... 194K€ Cerrado

GlycanTrigger GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMAT... 7M€ Cerrado

I-AM-GUT Impact of maternal Adrenomedullin on the Microbiome and Gut... 185K€ Cerrado

PD-GUT Parkinson s disease does it all start with gut inflammation... 2M€ Cerrado

Duración del proyecto: 68 meses Fecha Inicio: 2020-02-17
Fecha Fin: 2025-10-31

Líder del proyecto

UNIVERSITE DU LUXEMBOURG No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 2M€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The human gut microbiome is a complex ecosystem, which contributes essential functions to human physiology. Changes to the microbiome are associated with several chronic diseases characterised by inflammation, including neurodegenerative and autoimmune diseases. Microbiome-derived effector molecules comprising nucleic acids, (poly)peptides and metabolites are present at high levels in the gut but have so far eluded systematic study. This gap in knowledge is limiting mechanistic understanding of the microbiome’s functional impact on chronic diseases such as Parkinson’s disease (PD) and rheumatoid arthritis (RA). Here, I will for the first time integrate a combination of advanced high-resolution methodologies to comprehensively identify the constituents of this molecular complex and their impact on the human immune system. First, I will perform a quantitative, integrated multi-omic analysis on microbiome samples collected from healthy individuals and patients with newly diagnosed PD or RA. I will integrate and analyse the data using a newly developed knowledge base. Using contextualised prior knowledge (ExpoBiome Map) and machine learning methods, I will identify microbial molecules associated with condition-specific immunophenotypes. Second, I will validate and track the biomarker signature during a model clinical intervention (therapeutic fasting) to predict treatment outcomes. Third, microbes and molecules will be screened in personalised HuMiX gut-on-chip models to identify novel anti-inflammatory compounds. By providing mechanistic insights into the molecular basis of human-microbiome interactions, the project will generate essential new knowledge about causal relationships between the gut microbiome and the immune system in health and disease. By facilitating the elucidation of currently unknown microbiome-derived molecules, it will identify new genes, proteins, metabolites and host pathways for the development of future diagnostic and therapeutic applications.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores